ARCEDI’s mission is to provide pregnant women with a safe, simple and accurate cell-based non-invasive prenatal diagnosis (cbNIPD) by isolating fetal cells from maternal blood for genomic analysis of the fetus

ARCEDI Biotech ApS is a Danish biotech company involved in developing technologies for cell based noninvasive prenatal diagnosis (cbNIPD).

ARCEDI Biotech has proprietary method to enrich fetal cells from circulating maternal blood with high efficiency. Once enriched, the fetal cells can be utilized for downstream analysis using technologies such as FISH, array CGH, Next Generation Sequencing, etc. for the detection of chromosomal and subchromosomal changes in the fetal genome.


Anne-Marie Bruun

Managing Laboratory Technologist

Anne Katrine Rasmussen

Laboratory Technologist

Anne Schelde Høy

Research Assistant

Brit Andersen

Manager Commercial Activities

Bolette Nicolaisen

Quality Assurance Manager, MSc

Emmeli Mikkelsen

PhD Student

Inga B Christensen

Chief Operating Officer, PhD

Jakob Hedegaard

Sr. Clinical Application Manager, PhD

Katarina Ravn

Laboratory Director, Cand. Polyt

Line Dahl Jeppesen

PhD Student, MSc

Lotte Hatt

Chief Scientific Officer, PhD

Lotte Munkholm Hansen

Laboratory Technologist

Maiken Bruun Kristensen

Laboratory Technologist

Mathias Kølvraa

Chief Information Officer

Mette Overgaard

Laboratory Technologist

Palle Schelde

Chief Executive Officer

Peter Schelde Høy

Research Assistant

Ripudaman Singh

Chief Technology Officer, PhD, MBA

Simone Klavsen

Laboratory Technologist

Gitte Brix

Laboratory Technologist

Maibritt Nørgaard Lauridsen

Laboratory Clinical Geneticist, PhD

Marlene Christina Nielsen

Molecular Biologist, PhD

Maria Bach Laursen

Laboratory Clinical Geneticist, PhD

Mads Tang Dalsgaard

Chief Executive Officer, PhD


Our vision is to fundamentally transform prenatal diagnostics by making cell-free non-invasive prenatal testing (cfNIPT), chorionic villus sampling (CVS) and amniocentesis (Amnio) obsolete.


Our mission is to provide pregnant women a safe, simple and accurate cell-based non-invasive prenatal diagnosis (cbNIPD) by isolating and extracting fetal calls from maternal blood for genomic analysis of the fetus.


Aarhus University Hospital

The EVITA TEST has been developed in close collaboration with the Department for Ultrasound/Department for Obstetrics and Gynecology and the Department of Clinical Genetics at the Aarhus University Hospital. The scientific collaboration has evolved since 2005 and fundamentally contributed to the achievement of several milestones and results in the research.

Palle Juul-Jensens Boulevard 99
8200 Aarhus N, Denmark

Bagger-Sørensen & Co. A/S

Since 2013 Bagger-Sorensen & Co. A/S has been financial partner in ARCEDI Biotech. Bagger-Sorensen & Co. A/S is the holding and investment company of the Bagger-Sorensen family based in Vejle, Denmark.

Tabletvej 1
7100 Vejle, Denmark